STERIS to Invest $600 Million in New North Carolina Manufacturing Facility
What's Happening
STERIS has announced plans to invest $600 million in a new manufacturing facility in North Carolina, expanding its production capacity for sterilization chemicals used by hospitals, pharmaceutical companies, and medical device manufacturers.
The new facility will produce ethylene oxide (EtO), a sterilization chemical widely used to sterilize medical devices that cannot withstand high-temperature sterilization methods. The investment is expected to strengthen STERIS' manufacturing network while helping meet growing demand for sterilization services across the healthcare industry.
The expansion reflects continued investment in healthcare infrastructure as demand for sterile medical products continues to increase worldwide.
Understanding Ethylene Oxide Sterilization
Ethylene oxide (EtO) is one of the most commonly used sterilization methods for medical devices.
It is particularly important for products that cannot be sterilized using steam or radiation, including:
- Surgical instruments.
- Catheters.
- Implantable medical devices.
- Syringes.
- Wound care products.
- Diagnostic equipment.
Because EtO can sterilize complex devices without damaging sensitive materials, it remains a critical part of the global medical device supply chain.
Why the Investment Matters
Demand for sterilization services continues to grow as healthcare systems perform more surgeries and use increasing numbers of single-use medical devices.
The new manufacturing hub is expected to:
- Increase production capacity.
- Improve supply chain reliability.
- Support medical device manufacturers.
- Expand domestic manufacturing capabilities.
- Strengthen healthcare infrastructure.
The investment also comes as healthcare companies seek to reduce supply chain disruptions and improve access to essential sterilization materials.
Industry Impact
- Medical Device Manufacturers: Additional sterilization capacity will help manufacturers maintain production while meeting increasing regulatory and quality requirements.
- Healthcare Providers: Hospitals and surgical centers rely on sterile medical devices to reduce infection risk and ensure patient safety.
- Pharmaceutical Companies: Expanded production supports the safe manufacturing and packaging of sterile pharmaceutical products.
- Healthcare Supply Chain: The investment strengthens domestic manufacturing capacity for an essential component of the healthcare supply chain.
Looking Ahead
Construction of the new facility is expected to support long-term growth in demand for sterilization chemicals and services.
STERIS plans to continue expanding its manufacturing capabilities while supporting healthcare providers and medical device manufacturers with reliable sterilization solutions.
The investment may also encourage additional healthcare manufacturing expansion as demand for sterile medical products continues to rise.
Why This Matters
Sterilization plays a vital role in modern healthcare by helping prevent healthcare-associated infections and ensuring the safety of medical devices used in patient care.
STERIS' investment demonstrates the importance of strengthening domestic healthcare manufacturing and supporting resilient medical supply chains.
As demand for advanced medical devices continues to grow, reliable sterilization infrastructure will remain essential for maintaining patient safety and healthcare quality.
Key Takeaways
- STERIS will invest $600 million in a new manufacturing facility in North Carolina.
- The plant will produce ethylene oxide used to sterilize medical devices.
- The investment expands domestic manufacturing capacity for essential healthcare products.
- Increased sterilization capacity will support hospitals, pharmaceutical companies, and medical device manufacturers.
- The project reflects continued investment in healthcare infrastructure and supply chain resilience.
What This Means for Healthcare Marketers
STERIS' investment highlights continued growth in medical device manufacturing, infection prevention, sterilization technologies, and healthcare supply chain infrastructure. Medical device companies, hospitals, pharmaceutical manufacturers, and healthcare logistics providers continue investing in solutions that improve patient safety and manufacturing resilience. For healthcare marketers, organizations involved in sterilization services, infection prevention, MedTech manufacturing, and healthcare infrastructure represent high-intent opportunities for provider education, partnership development, commercial expansion, and strategic growth.